PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $75.17 million. The enterprise value is $40.48 million.
Important Dates
The next estimated earnings date is Monday, February 9, 2026, after market close.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 21.35 million shares outstanding. The number of shares has increased by 0.98% in one year.
| Current Share Class | 21.00M |
| Shares Outstanding | 21.35M |
| Shares Change (YoY) | +0.98% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 7.67% |
| Owned by Institutions (%) | 27.46% |
| Float | 13.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | n/a |
| PB Ratio | 1.75 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.05 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.91 |
Financial Efficiency
Return on equity (ROE) is -78.89% and return on invested capital (ROIC) is -24.56%.
| Return on Equity (ROE) | -78.89% |
| Return on Assets (ROA) | -14.11% |
| Return on Invested Capital (ROIC) | -24.56% |
| Return on Capital Employed (ROCE) | -63.74% |
| Revenue Per Employee | $1.15M |
| Profits Per Employee | -$318,052 |
| Employee Count | 173 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 10.06 |
Taxes
In the past 12 months, PetMed Express has paid $6.15 million in taxes.
| Income Tax | 6.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.26% in the last 52 weeks. The beta is 0.77, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -27.26% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 3.12 |
| Relative Strength Index (RSI) | 72.13 |
| Average Volume (20 Days) | 7,696,905 |
Short Selling Information
The latest short interest is 1.60 million, so 7.51% of the outstanding shares have been sold short.
| Short Interest | 1.60M |
| Short Previous Month | 1.57M |
| Short % of Shares Out | 7.51% |
| Short % of Float | 11.77% |
| Short Ratio (days to cover) | 8.16 |
Income Statement
In the last 12 months, PetMed Express had revenue of $198.27 million and -$55.02 million in losses. Loss per share was -$2.65.
| Revenue | 198.27M |
| Gross Profit | 58.15M |
| Operating Income | -27.80M |
| Pretax Income | -48.88M |
| Net Income | -55.02M |
| EBITDA | -19.58M |
| EBIT | -27.80M |
| Loss Per Share | -$2.65 |
Full Income StatementBalance Sheet
The company has $36.10 million in cash and $768,000 in debt, giving a net cash position of $35.33 million or $1.65 per share.
| Cash & Cash Equivalents | 36.10M |
| Total Debt | 768,000 |
| Net Cash | 35.33M |
| Net Cash Per Share | $1.65 |
| Equity (Book Value) | 43.06M |
| Book Value Per Share | 2.05 |
| Working Capital | 2.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.60 million and capital expenditures -$7.08 million, giving a free cash flow of -$395,000.
| Operating Cash Flow | -8.60M |
| Capital Expenditures | -7.08M |
| Free Cash Flow | -395,000 |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 29.33%, with operating and profit margins of -14.02% and -27.75%.
| Gross Margin | 29.33% |
| Operating Margin | -14.02% |
| Pretax Margin | -24.65% |
| Profit Margin | -27.75% |
| EBITDA Margin | -9.88% |
| EBIT Margin | -14.02% |
| FCF Margin | n/a |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.98% |
| Shareholder Yield | -0.98% |
| Earnings Yield | -72.58% |
| FCF Yield | -0.52% |
Dividend DetailsAnalyst Forecast
The average price target for PetMed Express is $3.20, which is -9.09% lower than the current price. The consensus rating is "Sell".
| Price Target | $3.20 |
| Price Target Difference | -9.09% |
| Analyst Consensus | Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 2.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.29 |
| Piotroski F-Score | 1 |
